Abivax se conforme aux recommandations du DSMB d'arrêt de l'étude clinique miR-AGE de phase 2b/3 dans la Covid-19 en raison d'un manque d'efficacité
Vendredi, mars 5, 2021 - 8:01pm
The study has a robust randomized, double-blind and placebo-controlled design to test whether ABX464 could prevent the development of severe Covid-19 disease in the participants.
The company Blade SAS, the specialist of cloud PC for video game players, was placed in receivership proceedings by the Paris Commercial Court yesterday.
The peer-reviewed article scientifically confirms the quality and robustness of the data generated in Abivax's randomized placebo-controlled, double-blind clinical study that consisted of an eight-week induction phase followed by an open-label long-term extension phase .